(1) Background: Different clinical presentations in COVID-19 are described to date, from
mild to severe cases. This study aims to identify different clinical phenotypes in COVID-19 …

Background The WHO ordinal severity scale has been used to predict mortality and guide
trials in COVID-19. However, it has its limitations. Objective The present study aims to …

Introduction The results of studies of tocilizumab (TCZ) in COVID‐19 are contradictory. Our
study aims to update medical evidence from controlled observational studies and randomized …

Background Hereditary hemorrhagic telangiectasia (HHT) is a rare vascular disease with
autosomal dominant inheritance. Disease-causing variants in endoglin (ENG) and activin A …

Background: We aimed to describe risk factors for gastrointestinal (GI) bleeding and endoscopic
findings in patients with hereditary hemorrhagic telangiectasia (HHT). Methods: This is a …

Background A higher incidence of thrombotic events, mainly pulmonary embolism (PE), has
been reported in hospitalized patients with COVID-19. The main objective was to assess …

Corticosteroids are largely recommended in patients with severe COVID-19. However,
evidence to support high-dose methylprednisolone (MP) pulses is not as robust as that …

Background: Chronic bleeding due to gastrointestinal (GI) involvement in patients with
hemorrhagic hereditary telangiectasia (HHT) can provoke severe anemia with high red blood …

Background Gender differences in organ involvement and clinical severity have been poorly
described in hereditary hemorrhagic telangiectasia (HHT). The aim of this study was to …

Background Adrenomedullin (AM) is a vasoactive peptide mostly secreted by endothelial
cells with an important role in preserving endothelial integrity. The relationship between AM …